Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Sphingolipids in Alzheimer's disease, how can we target them?
HTML
Details
Locations
Year:
2020
Type:
review
Source:
Advanced Drug Delivery Reviews
DOI:
10.1016/j.addr.2019.12.003
Authors:
Simone M. Crivelli,
Caterina Giovagnoni,
Lars Visseren,
Anna-Lena Scheithauer,
Nienke de Wit,
Sandra den Hoedt,
Mario Losen,
Monique T. Mulder,
Jochen Walter,
Helga E. de Vries,
Erhard Bieberich,
Pilar Martinez-Martinez
show all 12
Institutions:
University of Kentucky,
Maastricht University,
University of Bonn,
Amsterdam Neuroscience,
Amsterdam UMC,
Vrije Universiteit Amsterdam,
Erasmus MC,
Amsterdam Cardiovascular Sciences,
University of Amsterdam
show all 9
Language:
English
Topic:
Sphingolipid Metabolism and Signaling
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
sphingolipids,
Alzheimer's disease,
ceramide,
sphingolipid metabolism,
second messengers,
neurodegeneration,
neuronal homeostasis,
neuroinflammation,
pharmacological targeting,
drug repurposing
show all 10
SDG:
Good health and well-being
Open Access status:
green
Funders:
National Science Foundation,
U.S. Department of Veterans Affairs,
University of Kentucky,
ZonMw,
Universiteit Maastricht,
Elektrobit,
Internationale Stichting Alzheimer Onderzoek,
Alzheimer Nederland
show all 8
Awards:
G1026085362,
G195491957,
G1987605872,
G3973945030,
G5740738614,
Regulation of motile cilia by (phyto)ceramide,
G8166086896
show all 7
OpenAlex ID:
W2997802362
FWCI:
1.232
Cites:
363
Cited by:
91
Related to:
10